PRINCETON, N.J., Aug. 31, 2026 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, announced today the pricing of an underwritten public offering consisting of (i) 22,055,000 shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase an aggregate of up to 19,900,000 shares of its common stock, and (ii) accompanying warrants to purchase an aggregate of 41,955,000 shares of common stock. The common stock and pre-funded warrants are being sold in combination with an accompanying warrant to purchase one share of common stock for each share of common stock or pre-funded warrant sold. The accompanying warrants have an initial exercise...

An Important Step Forward for Access to LEQEMBI® for Eligible Patients in Canada TOKYO and CAMBRIDGE, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) — Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced today that Canada’s Drug Agency (CDA-AMC) has issued a final recommendation supporting public reimbursement of LEQEMBI® (lecanemab) for eligible patients in Canada living with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (early AD). The final recommendation follows a reconsideration by CDA-AMC and is an important step toward access to LEQEMBI. Next steps include negotiations through the pan-Canadian Pharmaceutical Alliance (pCPA), followed by individual reimbursement decisions by public drug plans in Canada’s provinces and territories. More than 770,000 people in Canada were estimated to be living with...

At a glanceNetwork readiness: Verizon has prepared its network with backup generators, satellite assets, and pre-staged equipment designed for reliability during severe weather. Customer resources: Verizon offers digital preparedness steps to help the community stay connected and secure ahead of the storm. Satellite messaging: Verizon customers can maintain essential communications via satellite, allowing compatible phones to send text messages or connect with emergency services.HOUSTON, Aug. 31, 2026 (GLOBE NEWSWIRE) — As potential Tropical Storm Edouard forms in the Gulf, Verizon has readied its network and remains on standby to ensure connectivity. Verizon Prepares Network along Gulf CoastVerizon’s network infrastructure in Houston and Louisiana is engineered to withstand severe weather. A significant portion is backed by...

Shares of Combined Company, to Be Renamed XTEND AI Robotics, Expected to Begin Trading on the NYSE Under the Ticker Symbol “XTND” on September 4, 2026 TAMPA, Fla., Aug. 31, 2026 (GLOBE NEWSWIRE) — JFB Construction Holdings (Nasdaq: JFB) and XTEND, a leader in software systems and artificial intelligence-powered robotics, announced today that the previously announced business combination between JFB and XTEND Reality Expansion Ltd. remains on track to close on September 3, 2026. Upon closing, the combined company will be renamed XTEND AI Robotics, Inc., and its common stock is expected to begin trading on the New York Stock Exchange (“NYSE”) under the ticker symbol “XTND” on September 4, 2026. JFB’s Class A common stock is expected to cease trading on the Nasdaq Stock Market after the close of trading hours on September 3, 2026. The...

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, today announced its financial results for the three and six months ended June 30, 2026 (“Q2 2026” and “YTD 2026”, respectively), and provided an update on recent corporate developments. Q2 2026 Financial HighlightsResearch and development (R&D) expenses of $1,130,259 for Q2 2026 and $2,161,815 YTD 2026, compared to $1,611,985 in the same period in 2025, reflecting lower contract research and consulting costs partially offset by increased chemistry and AI research activity. General and administrative (G&A) expenses of $450,695 for Q2...

Wilmington, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) — Ashland Inc. (NYSE: ASH) will host a live Innovation Day webcast for analysts and investors from Wilmington, Delaware on September 17, 2026. The event will provide an updated view of Ashland’s Technology Platforms, including their commercial progress and scalability.  Registration is required and can be accessed from the following link: innovationday26.ashland.com Participants will hear from Ashland executives and senior technology leaders as they provide an in-depth review of the latest innovations and expanding commercial opportunities. The presentations will detail how these advancements are poised to impact key markets and drive organic growth. Following formal remarks, participants will have the opportunity to engage directly in a moderated question and answer (Q&A) session. Ashland...

MISSISSAUGA, Ontario, Aug. 31, 2026 (GLOBE NEWSWIRE) — Bird Construction Inc. (TSX: BDT) announced today that Piinahzii Limited Partnership (“Piinahzii LP”) has signed an agreement to expand the scope of the partnership to include the Marten Falls Community Access Road. Piinahzii LP is a majority Indigenous-owned partnership formed by Marten Falls First Nation and Bird earlier this year. Aligned with the recent announcement by the Province of Ontario marking the ground breaking for the Marten Falls Community Access Road, the amended agreement expands Piinahzii LP’s role beyond community infrastructure and readiness work, to include construction of the access road itself. The agreement builds on the existing framework for jointly pursuing and executing infrastructure projects within the community and the Marten Falls First Nation...

David Gill appointed Chair of the Telix Board, effective immediately. Mr. Gill joined Telix as a Non-Executive Director in May 2026, with the intention that he would become Chair. Dr. Mark Nelson will continue to serve on the Board as a Non-Executive Director, having served as interim Chair.MELBOURNE, Australia and INDIANAPOLIS, Sept. 01, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix” or the “Company”) today announces that David Gill has been appointed Chair of the Board, effective immediately. Mr. Gill joined Telix as a Non-Executive Director in May 2026 as part of the Company’s Board expansion and succession planning1, with the intention that he would be appointed Chair in due course. He succeeds Dr. Mark Nelson, who has served as interim Chair and will remain on the Board as a Non-Executive...